Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Monopar Therapeutics Inc.
Market Cap
$534.45M
Interest Coverage Ratio
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO |
|---|---|---|
| Monopar Therapeutics Inc. (MNPR) | $534.45M | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $529.90M | -2.35x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $535.09M | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $535.43M | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $535.61M | N/A |
| ProKidney Corp. (PROK)vs › | $536.32M | -41251.75x |
| Immix Biopharma, Inc. (IMMX)vs › | $520.08M | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $536.98M | N/A |
| Shattuck Labs, Inc. (STTK)vs › | $538.62M | N/A |
| Altimmune, Inc. (ALT)vs › | $517.30M | -57.76x |
Interest Coverage
N/A
Debt/Equity
0.00
Current Ratio
33.56
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
